Skip to main content
Log in

Vitamin D insufficiency is associated with higher carotid intima-media thickness in psoriatic patients

  • Investigative Report
  • Published:
European Journal of Dermatology Aims and scope

Abstract

Background

Psoriasis has been associated with vitamin D insufficiency and cardiovascular risk factors. Reports show that serum 25-hydroxyvitamin D (25-OHD) levels are inversely associated with chronic inflammatory systemic diseases, cardiovascular risk factors and cardiovascular outcomes.

Objective

To analyze the association between 25-hydroxyvitamin D serum levels and subclinical carotid atherosclerosis (maximal intima-media thickness (MIMT)) in psoriasis patients and controls. MIMT was compared and associated factors were analyzed.

Patients and Method

This was a case-control study with 44 psoriatic patients without arthritis from a Dermatology outpatient clinic in Granada (Spain) and 44 controls. Confounding factors related to 25-OHD serum levels and cardiovascular risk factors were also analyzed.

Results

25-OHD levels were significantly lower in the psoriatic than in the control group (29.20 vs. 38.00 ng/mL p<0.0001) and a significant negative correlation was found between serum 25-OHD levels and the MIMT (rs = −0.678, p<0.0001) in psoriatic patients. No correlation was found in healthy controls. This association remained after adjusting for confounders. Serum 25-OHD levels were significantly lower (p = 0.003) in psoriatic patients with carotid atheromatous plaque (22.38 ± 10.23 ng/mL) than in those without (31.74 ± 8.62 ng/mL). Patients with a longer history of psoriasis presented significantly higher MIMT than controls (638.70 ± 76.21 vs 594.67 ± 80.20 μm; p = 0.026 for ≥6 yrs with psoriasis).

Conclusions

In psoriasis patients, lower serum 25-OHD levels were associated with higher MIMT after adjusting for selected confounding factors. The MIMT risk increases with a longer history of psoriasis, regardless of the patient’s age.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Späh F. Inflammation in atherosclerosis and psoriasis: common pathogenic mechanisms and the potential for an integrated treatment approach. Br J Dermatol 2008; 159(Suppl. 2): 10–17.

    Article  PubMed  Google Scholar 

  2. O’Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group.NEngl J Med 1999; 340: 14–22.

    Google Scholar 

  3. Rundek T, Arif H, Boden-Albala B, Elkind MS, Paik MC, Sacco RL. Carotid plaque, a subclinical precursor of vascular events: the Northern Manhattan Study. Neurology 2008; 70: 1200–1207.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  4. Salonen R, Salonen JT. Determinants of carotid intima-media thickness: a population-based ultrasonography study in eastern Finnish men. J Intern Med 1991; 229: 225–231.

    Article  CAS  PubMed  Google Scholar 

  5. Bokemark L, Wikstrand J, Attvall S, et al. Insulin resistance and intima-media thickness in the carotid and femoral arteries of clinically healthy 58-year-old men. The Atherosclerosis and Insulin Resistance Study (AIR). J Intern Med 2001; 249: 59–67.

    CAS  PubMed  Google Scholar 

  6. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352: 1685–1695.

    Article  CAS  PubMed  Google Scholar 

  7. Arias-Santiago S, Orgaz-Molina J, Castellote-Caballero L, et al. Atheroma plaque, metabolic syndrome and inflammation in patients with psoriasis. Eur J Dermatol 2012; 22: 337–344.

    CAS  PubMed  Google Scholar 

  8. Zold E, Barta Z, Bodolay E. Vitamin D deficiency and connective tissue disease. Vitam Horm 2011; 86: 261–286.

    Article  CAS  PubMed  Google Scholar 

  9. Gisondi P, Rossini M, Di Cesare A, et al. Vitamin D status in patients with chronic plaque psoriasis. Br J Dermatol 2012; 166: 505–510.

    Article  CAS  PubMed  Google Scholar 

  10. Orgaz-Molina J, Buendía-Eisman A, Arrabal-Polo MA, Ruiz JC, Arias-Santiago S. Deficiency of serum concentration of 25-hydroxyvitamin D in psoriatic patients: A case-control study. J Am Acad Dermatol 2012; 67: 931–938.

    Article  CAS  PubMed  Google Scholar 

  11. Hewison M. Vitamin D and the immune system: new perspectives on an old theme. Endocrinol Metab Clin North Am 2010; 39: 365–379.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  12. Scragg R, Jackson R, Holdaway IM, Lim T, Beaglehole R. Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study. Int J Epidemio 1990; 19: 559–563.

    Article  CAS  Google Scholar 

  13. Poole KE, Loveridge N, Barker PJ, et al. Reduced vitamin D in acute stroke. Stroke 2006; 37: 243–245.

    Article  CAS  PubMed  Google Scholar 

  14. Wang T, Pencina M, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008; 117: 503–511.

    Article  CAS  PubMed  Google Scholar 

  15. Dobnig H, Pilz S, Scharnagl H, et al. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med 2008; 168: 1340–1349.

    Article  CAS  PubMed  Google Scholar 

  16. Zhang R, Naughton DP. Vitamin D in health and disease: current perspectives. Nutr J 2010; 9: 65.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  17. Emaus A, Degerstrøm J, Wilsgaard T, et al. Does a variation in self-reported physical activity reflect variation in objectively measured physical activity, resting heart rate, and physical fitness? Results from the Tromso study. Scand J Public Health. 2010; 38(Suppl. 5): 105–118.

    Article  PubMed  Google Scholar 

  18. Stein JH, Korcarz CE, Hurst RT, et al. American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr 2008; 21: 93–111.

    Article  PubMed  Google Scholar 

  19. Stensland-Bugge E, Bønaa KH, Joakimsen O. Reproducibility of ultrasonographically determined intima-media thickness is dependent on arterial wall thickness. The Tromsø Study. Stroke 1997; 28: 1972–1980.

    Article  CAS  PubMed  Google Scholar 

  20. O’Leary DH, Polak JF. Intima-media thickness: a tool for atherosclerosis imaging and event prediction. American Journal of Cardiology 2002; 90: 18–21.

    Article  Google Scholar 

  21. Ross AC, Judd S, Kumari M, et al. Vitamin D is linked to carotid intima-media thickness and immune reconstitution in HIV-positive individuals. Antivir Ther 2011; 16: 555–563.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  22. Choi AI, Lo JC, Mulligan K, et al. Association of vitamin D insufficiency with carotid intima-media thickness in HIV-infected persons. Clin Infect Dis 2011; 52: 941–944.

    Article  PubMed Central  PubMed  Google Scholar 

  23. Targher G, Bertolini L, Padovani R, et al. Serum 25-hydroxyvitamin D3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients. Clin Endocrinol 2006; 65: 593–597.

    Article  CAS  Google Scholar 

  24. Richart T, Thijs L, Nawrot T, et al. The metabolic syndrome and carotid intima-media thickness in relation to the parathyroid hormone to 25-OH-D(3) ratio in a general population. Am J Hypertens 2011; 24: 102–109.

    Article  CAS  PubMed  Google Scholar 

  25. Sachs MC, Brunzell JD, Cleary PA, et al. Circulating vitamin d metabolites and subclinical atherosclerosis in type 1 diabetes. Diabetes Care 2013; 36: 2423–2429.

    Article  CAS  PubMed  Google Scholar 

  26. Rosenblatt J, Bissonnette A, Ahmad R, et al. Immunomodulatory effects of vitamin D: implications for GVHD. Bone Marrow Transplant 2010; 45: 1463–1468.

    Article  CAS  PubMed  Google Scholar 

  27. Oh J, Weng S, Felton SK, et al. 1,25(OH)2 vitamin d inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus. Circulation 2009; 120: 687–698.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  28. Andress DL. Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation. Kidney Int 2006; 69: 33–43.

    Article  CAS  PubMed  Google Scholar 

  29. Sun J, Kong J, Duan Y, et al. Increased NF-kappaβ activity in fibroblasts lacking the vitamin D receptor. Am J Physiol Endocrinol Metab 2006; 291: E315–E322.

    Article  CAS  PubMed  Google Scholar 

  30. Kasuga H, Hosogane N, Matsuoka K, et al. Characterization of transgenic rats constitutively expressing vitamin D-24-hydroxylase gene. Biochem Biophys Res Commun 2002; 297: 1332–1338.

    Article  CAS  PubMed  Google Scholar 

  31. Mok CC, Birmingham DJ, Leung HW, Hebert LA, Song H, Rovin BH. Vitamin D levels in Chinese patients with systemic lupus erythematosus: relationship with disease activity, vascular risk factors and atherosclerosis. Rheumatology 2012; 51: 644–652.

    Article  CAS  PubMed  Google Scholar 

  32. Karhapää P, Pihlajamäki J, Pörsti I, et al. Diverse associations of 25-hydroxyvitamin D and 1,25-dihydroxy-vitamin D with dyslipidaemias. J Intern Med. 2010; 268: 604–610.

    Article  PubMed  Google Scholar 

  33. Rodríguez-Rodríguez E, Ortega RM, González-Rodríguez LG, López-Sobaler AM, UCM Research Group VALORNUT (920030) AM. Vitamin D deficiency is an independent predictor of elevated triglycerides in Spanish school children. Eur J Nutr 2011; 50: 373–378.

    Article  PubMed  Google Scholar 

  34. Forouhi NG, Luan J, Cooper A, Boucher BJ, Wareham NJ. Baseline serum 25-hydroxy vitamin D is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990–2000. Diabetes 2008; 57: 2619–2625.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  35. Liu E, Meigs JB, Pittas AG, et al. Plasma 25-hydroxyvitamin D is associated with markers of the insulin resistant phenotype in nondiabetic adults. J Nutr 2009; 139: 329–334.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  36. Lau SL, Gunton JE, Athayde NP, Byth K, Cheung NW. Serum 25-hydroxyvitamin D and glycated haemoglobin levels in women with gestational diabetes mellitus. Med J Aus 2011; 194: 334–337.

    Google Scholar 

  37. Johnson JA, Grande JP, Roche PC, Kumar R. Immunohistochemical localization of the 1,25(OH)2D3 receptor and calbindin D28k in human and rat pancreas. Am J Physiol 1994; 267: E356–E360.

    CAS  PubMed  Google Scholar 

  38. Bland R, Markovic D, Hills CE, et al. Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in pancreatic islets. J Steroid Biochem Mol Biol 2004; 89-90: 121–125.

    Article  CAS  PubMed  Google Scholar 

  39. Cade C, Norman AW. Vitamin D3 improves impaired glucose tolerance and insulin secretion in the vitamin D-deficient rat in vivo. Endocrinology 1986; 119: 84–90.

    Article  CAS  PubMed  Google Scholar 

  40. Sabanayagam C, Shankar A, Somasundaram S. Serum Vitamin D Level and Prehypertension among Subjects Free of Hypertension. Kidney Blood Press Res 2012; 35: 106–113.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  41. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002; 110: 229–238.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  42. Li YC. Vitamin D regulation of the renin-angiotensin system. J Cell Biochem 2003; 88: 327–331.

    Article  CAS  PubMed  Google Scholar 

  43. Zittermann A, Koerfer R. Vitamin D in the prevention and treatment of coronary heart disease. Curr Opin Clin Nutr Metab Care 2008; 11: 752–757.

    Article  CAS  PubMed  Google Scholar 

  44. Mitsuhashi T, Morris RC Jr., Ives HE. 1,25-Dihydroxyvitamin D3 modulates growth of vascular smooth muscle cells. J Clin Invest 1991; 87: 1889–1895.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  45. Rigby WF, Denome S, Fanger MW. Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3: specific inhibition at the level of messenger RNA. J Clin Invest 1987; 79: 1659–1664.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  46. Jorde R, Figenschau Y, Hutchinson M, Emaus N, Grimnes G. High serum 25-hydroxyvitamin D concentrations are associated with a favorable serum lipid profile. Eur J Clin Nutr 2010; 64: 1457–1464.

    Article  CAS  PubMed  Google Scholar 

  47. Xiang W, Kong J, Chen S, et al. Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems. Am J Physiol Endocrinol Metab 2005; 288: E125–E132.

    Article  CAS  PubMed  Google Scholar 

  48. Scragg R, Sowers M, Bell C. Third National Health and Nutrition Examination Survey. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 2004; 27: 2813–2818.

    Article  CAS  PubMed  Google Scholar 

  49. Sabanayagam C, Shankar A, Somasundaram S. Serum Vitamin D Level and Prehypertension among Subjects Free of Hypertension. Kidney Blood Press Res 2012; 35: 106–113.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  50. Carrelli AL, Walker MD, Lowe H, et al. Vitamin D deficiency is associated with subclinical carotid atherosclerosis: the Northern Manhattan study. Stroke 2011; 42: 2240–2245.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  51. Di Minno MN, Iervolino S, Peluso R, Scarpa R, Di Minno G, CaRRDs study group G. Carotid intima-media thickness in psoriatic arthritis: differences between tumor necrosis factor-α blockers and traditional disease-modifying antirheumatic drugs. Arterioscler Thromb Vasc Biol 2011; 31: 705–712.

    Article  PubMed  Google Scholar 

  52. Hürlimann D, Forster A, Noll G, et al. Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis. Circulation 2002; 106: 2184–2187.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Salvador Arias-Santiago.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Orgaz-Molina, J., Magro-Checa, C., Rosales-Alexander, J.L. et al. Vitamin D insufficiency is associated with higher carotid intima-media thickness in psoriatic patients. Eur J Dermatol 24, 53–62 (2014). https://doi.org/10.1684/ejd.2013.2241

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1684/ejd.2013.2241

Keywords

Navigation